Julie Kjems
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julie Kjems has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jeppe Friborg
Department of Oncology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
5 shared publications - Ivan Richter Vogelius
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
3 shared publications - Jens Overgaard
Department of Experimental Clinical Oncology Aarhus University Hospital Aarhus Denmark
3 shared publications - Claus Andrup Kristensen
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
2 shared publications - Jørgen Johansen
Institute of Clinical Research, University of Southern Denmark, Denmark; Department of Oncology, Odense University Hospital, Denmark
2 shared publications - Lena Specht
Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
2 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (6) , 694-701
The clinical impact of 131-iodine whole-body scintigraphy following 131-iodine therapy of thyroid cancer
The incidence of thyroid cancer has increased globally in recent years, primarily due to a more widespread use of imaging particularly in terms of ultrasonography and subsequent biopsies [1]. The a...
- 18 August 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (6) , 694-701
Open AccessThe clinical impact of 131-iodine whole-body scintigraphy following 131-iodine therapy of thyroid cancer
The incidence of thyroid cancer has increased globally in recent years, primarily due to a more widespread use of imaging particularly in terms of ultrasonography and subsequent biopsies [1]. The a...
- Open Access
- 25 March 2024
- Published by Wiley in Head & Neck
- Vol. 46 (10) , 2532-2539
Separating distant recurrences from second primaries in head and neck squamous cell carcinomas – A DAHANCA group analysis on paired tumor samples
Background: In head and neck squamous cell carcinomas (HNSCC), there is no clinically available method to separate distant metastases (DMs) from SCC secondary primary tumors. The study aimed to assess the genetic relationship in paired tumor samples.Methods: Patients with pairs of solid biopsies from the primary HNSCC and suspected DMs were identified (2007–2017). Targeted next‐generation sequencing of 22 genes was applied, including TP53, supplemented with human papillomavirus (HPV) genotyping.Results: Of 55 pairs obtained, 33 were successfully analyzed. Distant biopsies included lung, liver, and bone. A genetic match was found in 23/33 (70%) patients, primarily with identical TP53 mutations or HPV genotypes. In 10/33 patients (30%), the genetic relationship was absent, all with lung involvement. In patients with no lung involvement, 8/8 had a match.Conclusions: One‐third of patients with DMs in HNSCC lack a genetic relationship with the primary tumors. The risk of misclassification is most prominent for patients with lung involvement.
- 25 March 2024
- Published by Wiley in Head & Neck
- Vol. 46 (10) , 2532-2539
Open AccessSeparating distant recurrences from second primaries in head and neck squamous cell carcinomas – A DAHANCA group analysis on paired tumor samples
Background: In head and neck squamous cell carcinomas (HNSCC), there is no clinically available method to separate distant metastases (DMs) from SCC secondary primary tumors. The study aimed to assess the genetic relationship in paired tumor samples.Methods: Patients with pairs of solid biopsies from the primary HNSCC and suspected DMs were identified (2007–2017). Targeted next‐generation sequencing of 22 genes was applied, including TP53, supplemented with human papillomavirus (HPV) genotyping.Results: Of 55 pairs obtained, 33 were successfully analyzed. Distant biopsies included lung, liver, and bone. A genetic match was found in 23/33 (70%) patients, primarily with identical TP53 mutations or HPV genotypes. In 10/33 patients (30%), the genetic relationship was absent, all with lung involvement. In patients with no lung involvement, 8/8 had a match.Conclusions: One‐third of patients with DMs in HNSCC lack a genetic relationship with the primary tumors. The risk of misclassification is most prominent for patients with lung involvement.
- 7 August 2023
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (9) , 1091-1095
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis
- 7 August 2023
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (9) , 1091-1095
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis
- Open Access
- 28 June 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 186, 109771
The influence of tumor volume on the risk of distant metastases in head and neck squamous cell carcinomas
- 28 June 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 186, 109771
Open AccessThe influence of tumor volume on the risk of distant metastases in head and neck squamous cell carcinomas
- 8 August 2021
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (11) , 1472-1480
Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study
In head and neck cancer, distant metastases may be present at diagnosis (M1) or occur after treatment (DM). It is unknown whether M1 and DM follow the same clinical development and share prognosis,...
- 8 August 2021
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (11) , 1472-1480
Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study
In head and neck cancer, distant metastases may be present at diagnosis (M1) or occur after treatment (DM). It is unknown whether M1 and DM follow the same clinical development and share prognosis,...
- 1 March 2016
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 94 (4) , 775-782
Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy
- 1 March 2016
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 94 (4) , 775-782
Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy